Comments: US HB383 | 2023-2024 | 118th Congress

Bill Title: To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.

Spectrum: Partisan Bill (Republican 27-0)

Status: (Introduced) 2023-01-27 - Referred to the Subcommittee on Health. [HB383 Detail]

Text: Latest bill text (Introduced) [PDF]

PolitiCorps Conversations

Start PolitiCorps Debate
TitlePolitiCorpsAccessCommentsViewsLast Post
There are no visible public or private PolitiCorps discussions concerning the 2023 US Congress HB383 at this time.

Social Comments on US HB383

feedback